Whole exome sequencing and the study of the tumor microenvironment in surgically resected specimens of NSCLC patients demonstrated low PDL1 expression, and a low percentage of CD3+ and CD8+ T-lymphocytes in LKB1 mutated patients. Here, STK11 is linked to non-small cell lung carcinoma.